Compare Medpace Holdings Inc (MEDP) vs Pinterest Inc (PINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Pinterest Inc — how do they compare? Medpace Holdings Inc trades at $612.05 (market cap $16.82B), while Pinterest Inc trades at $21.4 (market cap $11.63B). The key difference: Medpace Holdings Inc is the larger of the two by market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Pinterest Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Pinterest Inc for 85 Days on average.
| MEDP | PINS | |
|---|---|---|
Market Cap | $16.82B | $11.63B |
Volume | 223,093 | 12,792,940 |
Sector | Health | Media |
52-Week High | $630.19 | $35.24 |
52-Week Low | $393.42 | $15.42 |
Typical Hold Time | 14 Days | 85 Days |
Enterprise Value | $16.44B | $11.55B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medpace (MEDP) trades at $602.70, down 0.26% with neutral technical signals. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (17.67% net margin, 162.15% ROE). Recent CEO stock sales and mixed institutional activity create near-term uncertainty, though analyst consensus remains positive with a $620.44 price target. The company is scheduled to report Q3 2026 results on October 21, 2026.
MEDP presents a compelling growth story with strong financial metrics, though elevated valuations (P/E 35.41) and insider selling warrant caution. Upside potential exists if Q3 earnings meet expectations, while failure to maintain growth momentum could pressure the stock. The current price near pivot point ($599) suggests balanced risk-reward ahead of earnings.
Pinterest (PINS) trades at $20.525, up 1.06% with a bullish technical signal despite mixed oscillators. The company demonstrates strong revenue growth from $2.8B in 2022 to $4.2B in 2025, with consistent earnings beats in recent quarters. Analyst consensus is strongly positive with 54% buy ratings and a $27.93 price target, representing 36% upside potential from current levels.
PINS offers compelling growth potential driven by international monetization and visual search advertising innovations, though elevated valuation metrics (P/E 60.38) and insider selling activity warrant caution. The stock's primary catalysts include continued user growth and advertising revenue expansion, while risks center on competitive pressure and execution challenges in global markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Pinterest Inc
Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →
